| Code | Description | Claims | Beneficiaries | Total Paid |
| G0378 |
Hospital observation service, per hour |
15,233 |
13,297 |
$16.71M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
46,123 |
41,346 |
$16.60M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
52,151 |
46,370 |
$15.69M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
23,475 |
20,083 |
$4.45M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
4,820 |
2,974 |
$4.07M |
| S9480 |
Intensive outpatient psychiatric services, per diem |
4,979 |
4,252 |
$4.07M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
16,262 |
14,778 |
$3.91M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
3,979 |
3,884 |
$3.51M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
47,806 |
12,465 |
$3.41M |
| H0035 |
Mental health partial hospitalization, treatment, less than 24 hours |
10,376 |
1,252 |
$2.97M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,330 |
10,769 |
$2.07M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,173 |
2,066 |
$1.88M |
| OP370 |
|
16,995 |
14,587 |
$1.76M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
3,402 |
1,492 |
$1.68M |
| OP710 |
|
16,728 |
14,930 |
$1.66M |
| 90832 |
Psychotherapy, 30 minutes with patient |
15,993 |
7,361 |
$1.57M |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
1,253 |
1,155 |
$1.54M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
16,169 |
13,003 |
$1.44M |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
23,731 |
6,162 |
$1.29M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
13,539 |
4,861 |
$1.19M |
| G0330 |
Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room |
526 |
484 |
$1.14M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,071 |
3,784 |
$985K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
10,716 |
9,224 |
$969K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
7,540 |
7,068 |
$860K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
34,401 |
28,916 |
$860K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,703 |
1,638 |
$828K |
| OP278 |
|
1,057 |
927 |
$822K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,011 |
959 |
$815K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
9,110 |
6,179 |
$795K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
605 |
515 |
$770K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
11,126 |
9,787 |
$756K |
| 95816 |
|
1,436 |
1,399 |
$744K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
5,096 |
4,640 |
$702K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
402 |
396 |
$688K |
| 96415 |
|
1,463 |
1,037 |
$667K |
| 70450 |
Computed tomography, head or brain; without contrast material |
11,451 |
10,516 |
$606K |
| 80053 |
Comprehensive metabolic panel |
88,680 |
64,147 |
$587K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
18,752 |
16,728 |
$571K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
11,788 |
10,458 |
$563K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,616 |
1,553 |
$563K |
| 36430 |
|
931 |
582 |
$517K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
8,385 |
7,301 |
$505K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
2,179 |
2,120 |
$505K |
| 92587 |
|
2,070 |
2,006 |
$490K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,545 |
3,309 |
$471K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14,761 |
10,640 |
$461K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
208 |
202 |
$433K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
14,252 |
4,648 |
$429K |
| 95819 |
|
660 |
639 |
$418K |
| S9484 |
Crisis intervention mental health services, per hour |
540 |
513 |
$405K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
97,626 |
70,267 |
$399K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
11,083 |
7,967 |
$378K |
| 93976 |
|
2,834 |
2,692 |
$352K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
5,286 |
4,775 |
$335K |
| 36591 |
|
2,275 |
1,138 |
$325K |
| 71046 |
Radiologic examination, chest; 2 views |
22,140 |
20,425 |
$321K |
| 92567 |
|
2,719 |
2,584 |
$320K |
| OP250 |
|
131,973 |
63,496 |
$313K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
4,029 |
3,223 |
$305K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
6,651 |
6,382 |
$304K |
| 92557 |
|
880 |
848 |
$275K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,241 |
4,046 |
$268K |
| 96367 |
|
1,922 |
1,440 |
$265K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
8,531 |
5,875 |
$261K |
| OP272 |
|
20,279 |
18,489 |
$261K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
2,570 |
2,463 |
$240K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,537 |
2,317 |
$237K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
5,339 |
3,902 |
$227K |
| 59025 |
Fetal non-stress test |
934 |
720 |
$227K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
4,283 |
1,674 |
$220K |
| 99215 |
Prolong outpt/office vis |
923 |
813 |
$215K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
12,642 |
10,031 |
$213K |
| 90791 |
Psychiatric diagnostic evaluation |
5,157 |
4,333 |
$212K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
9,561 |
8,890 |
$211K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,427 |
2,291 |
$208K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,598 |
1,444 |
$206K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,793 |
3,524 |
$203K |
| 97161 |
|
3,745 |
3,519 |
$198K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
3,450 |
1,703 |
$195K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,734 |
2,586 |
$192K |
| 93017 |
|
681 |
633 |
$190K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,581 |
2,170 |
$188K |
| H0046 |
Mental health services, not otherwise specified |
3,791 |
2,939 |
$186K |
| OP259 |
|
15,498 |
10,912 |
$182K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
5,395 |
5,043 |
$178K |
| 92579 |
|
661 |
614 |
$170K |
| 93458 |
|
109 |
108 |
$165K |
| 93970 |
|
1,207 |
1,136 |
$164K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
361 |
331 |
$161K |
| 76813 |
|
1,765 |
1,724 |
$160K |
| 97010 |
|
18,887 |
5,169 |
$155K |
| 90870 |
|
617 |
164 |
$152K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,664 |
1,551 |
$151K |
| 36415 |
Collection of venous blood by venipuncture |
79,813 |
62,487 |
$137K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
512 |
476 |
$132K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
874 |
820 |
$120K |
| 92526 |
|
1,655 |
751 |
$118K |
| OP379 |
|
3,083 |
3,074 |
$116K |
| 70486 |
|
1,229 |
1,152 |
$114K |
| 95782 |
|
26 |
26 |
$113K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
7,851 |
6,249 |
$111K |
| 76801 |
|
1,796 |
1,651 |
$109K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
16,606 |
13,936 |
$104K |
| 76770 |
|
1,550 |
1,483 |
$103K |
| 76820 |
|
1,765 |
904 |
$100K |
| 84484 |
|
21,543 |
15,377 |
$98K |
| 93971 |
|
2,067 |
1,948 |
$96K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
403 |
372 |
$88K |
| 71045 |
Radiologic examination, chest; single view |
6,052 |
5,540 |
$87K |
| 96376 |
|
4,394 |
3,380 |
$85K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
155 |
141 |
$85K |
| 76821 |
|
1,194 |
594 |
$82K |
| 76830 |
Ultrasound, transvaginal |
1,504 |
1,457 |
$79K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
554 |
516 |
$75K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,323 |
4,005 |
$73K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,101 |
8,170 |
$72K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
29 |
24 |
$71K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
11,632 |
10,456 |
$71K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,879 |
1,815 |
$71K |
| 71250 |
|
930 |
876 |
$70K |
| 96417 |
|
207 |
131 |
$70K |
| 97165 |
|
1,248 |
1,184 |
$66K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
9,372 |
8,133 |
$64K |
| 97162 |
|
1,025 |
936 |
$58K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
9,833 |
7,973 |
$56K |
| 94762 |
|
351 |
342 |
$55K |
| 80061 |
Lipid panel |
6,240 |
5,766 |
$53K |
| 97116 |
|
2,603 |
1,574 |
$52K |
| 86885 |
|
8,914 |
7,794 |
$51K |
| J3490 |
Unclassified drugs |
6,878 |
5,342 |
$51K |
| 76536 |
|
836 |
802 |
$50K |
| G0379 |
Direct admission of patient for hospital observation care |
418 |
405 |
$50K |
| 99381 |
|
413 |
392 |
$48K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
256 |
242 |
$48K |
| 92523 |
|
297 |
294 |
$48K |
| OP258 |
|
55,311 |
36,922 |
$47K |
| 83735 |
|
18,292 |
11,318 |
$47K |
| 42830 |
|
37 |
37 |
$47K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,598 |
3,358 |
$47K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
2,591 |
2,035 |
$45K |
| 93975 |
|
512 |
504 |
$45K |
| OP270 |
|
9,630 |
8,861 |
$44K |
| 69421 |
|
38 |
35 |
$43K |
| 81003 |
|
20,155 |
18,506 |
$43K |
| C1769 |
Guide wire |
2,076 |
1,579 |
$42K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,611 |
3,438 |
$42K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,612 |
3,439 |
$42K |
| 0002A |
|
1,302 |
1,300 |
$42K |
| 90715 |
|
2,255 |
2,116 |
$41K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,141 |
522 |
$39K |
| 85610 |
|
11,961 |
9,653 |
$38K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
718 |
606 |
$38K |
| 0001A |
|
1,305 |
1,299 |
$38K |
| 74018 |
|
3,742 |
3,504 |
$37K |
| 77336 |
|
270 |
129 |
$37K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,059 |
1,875 |
$36K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
913 |
902 |
$35K |
| 82962 |
|
14,249 |
9,068 |
$33K |
| 73030 |
|
1,995 |
1,882 |
$32K |
| 93041 |
|
381 |
363 |
$32K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,559 |
5,999 |
$32K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
55 |
38 |
$31K |
| 97535 |
Self-care/home management training, each 15 minutes |
790 |
572 |
$31K |
| J2704 |
Injection, propofol, 10 mg |
14,363 |
12,019 |
$31K |
| 83690 |
|
13,719 |
12,214 |
$31K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
501 |
485 |
$31K |
| 83880 |
|
4,910 |
4,078 |
$30K |
| 86901 |
|
11,008 |
9,249 |
$30K |
| 73630 |
|
2,361 |
2,196 |
$30K |
| 86900 |
|
10,669 |
9,053 |
$30K |
| 85730 |
|
8,160 |
7,176 |
$29K |
| 73610 |
|
2,384 |
2,152 |
$29K |
| 70498 |
|
372 |
339 |
$28K |
| OP279 |
|
4,102 |
3,902 |
$28K |
| 87040 |
|
3,297 |
2,785 |
$28K |
| 92610 |
|
107 |
105 |
$28K |
| 82077 |
|
6,479 |
5,436 |
$28K |
| 58558 |
|
25 |
24 |
$27K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,541 |
1,374 |
$27K |
| OP682 |
|
114 |
113 |
$27K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
10,757 |
9,918 |
$26K |
| 81001 |
|
16,710 |
15,168 |
$26K |
| 72131 |
|
504 |
467 |
$25K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,547 |
3,246 |
$25K |
| 81025 |
|
12,351 |
11,303 |
$25K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
5,156 |
3,598 |
$23K |
| 87070 |
|
7,035 |
6,612 |
$23K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
449 |
405 |
$23K |
| 84100 |
|
11,868 |
7,395 |
$23K |
| OP229 |
|
463 |
415 |
$23K |
| 84439 |
|
3,883 |
3,512 |
$23K |
| 70496 |
|
303 |
273 |
$23K |
| 90670 |
|
806 |
695 |
$23K |
| J1644 |
Injection, heparin sodium, per 1000 units |
7,969 |
3,642 |
$23K |
| 72141 |
|
101 |
95 |
$22K |
| 84145 |
|
2,694 |
2,379 |
$22K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
21,228 |
17,428 |
$22K |
| 82728 |
|
3,045 |
2,478 |
$22K |
| 85027 |
|
6,547 |
5,254 |
$21K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,551 |
1,300 |
$21K |
| 73562 |
|
1,766 |
1,658 |
$20K |
| 73130 |
|
1,771 |
1,676 |
$20K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
13,173 |
12,054 |
$19K |
| 72110 |
|
812 |
777 |
$19K |
| 90677 |
|
589 |
557 |
$19K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
15,340 |
12,979 |
$19K |
| 86923 |
|
1,469 |
1,105 |
$19K |
| 83605 |
|
3,859 |
3,254 |
$18K |
| 84703 |
|
8,639 |
7,807 |
$18K |
| 73110 |
|
1,294 |
1,211 |
$17K |
| 83789 |
|
3,456 |
2,985 |
$17K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
19 |
12 |
$17K |
| 99153 |
Mod sedat endo service >5yrs |
1,258 |
1,145 |
$17K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
8,715 |
7,748 |
$16K |
| 82607 |
|
2,496 |
2,268 |
$16K |
| J1756 |
Injection, iron sucrose, 1 mg |
155 |
83 |
$16K |
| C1889 |
Implantable/insertable device, not otherwise classified |
33 |
26 |
$16K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15,248 |
12,342 |
$16K |
| 84702 |
|
3,451 |
2,979 |
$16K |
| 73590 |
|
1,155 |
1,060 |
$16K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
72 |
70 |
$15K |
| 88304 |
|
1,569 |
1,480 |
$15K |
| 86140 |
|
8,863 |
7,464 |
$15K |
| 77072 |
|
368 |
357 |
$14K |
| G0390 |
Trauma response team associated with hospital critical care service |
86 |
79 |
$14K |
| 90686 |
|
2,340 |
2,105 |
$14K |
| 87088 |
|
2,860 |
2,772 |
$14K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
13 |
13 |
$13K |
| 82803 |
|
1,863 |
1,597 |
$13K |
| 54640 |
|
14 |
13 |
$13K |
| 76870 |
|
514 |
485 |
$13K |
| 97022 |
|
538 |
163 |
$12K |
| 92550 |
|
85 |
77 |
$12K |
| 83550 |
|
2,827 |
2,355 |
$12K |
| 87186 |
|
2,835 |
2,532 |
$12K |
| 0004A |
|
351 |
336 |
$12K |
| 76818 |
|
245 |
214 |
$11K |
| 96401 |
|
33 |
26 |
$11K |
| J0185 |
Injection, aprepitant, 1 mg |
36 |
26 |
$11K |
| 73502 |
|
991 |
938 |
$11K |
| 95716 |
|
20 |
13 |
$11K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
13 |
13 |
$10K |
| 92611 |
|
36 |
36 |
$10K |
| 74174 |
|
103 |
92 |
$10K |
| 92588 |
|
31 |
27 |
$10K |
| 73564 |
|
618 |
568 |
$10K |
| 87077 |
|
3,071 |
2,616 |
$10K |
| 85379 |
|
3,151 |
2,888 |
$9K |
| 82550 |
|
2,917 |
2,445 |
$9K |
| 95700 |
|
35 |
29 |
$9K |
| 82746 |
|
1,626 |
1,476 |
$9K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,951 |
2,894 |
$9K |
| 54830 |
|
12 |
12 |
$9K |
| 80143 |
|
1,815 |
1,590 |
$8K |
| G0008 |
Administration of influenza virus vaccine |
479 |
469 |
$8K |
| 85651 |
|
4,361 |
3,890 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,365 |
3,307 |
$8K |
| 85045 |
|
2,468 |
1,998 |
$8K |
| 99152 |
|
1,359 |
1,257 |
$8K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
46 |
38 |
$8K |
| 80179 |
|
1,743 |
1,529 |
$8K |
| G0451 |
Development testing, with interpretation and report, per standardized instrument form |
311 |
308 |
$8K |
| 83540 |
|
2,624 |
2,127 |
$8K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
5,333 |
4,078 |
$8K |
| 88307 |
|
355 |
312 |
$8K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,583 |
2,024 |
$7K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
35 |
35 |
$7K |
| C1760 |
Closure device, vascular (implantable/insertable) |
282 |
235 |
$7K |
| J2785 |
Injection, regadenoson, 0.1 mg |
65 |
53 |
$7K |
| 76000 |
|
424 |
408 |
$7K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
630 |
562 |
$7K |
| J2060 |
Injection, lorazepam, 2 mg |
2,887 |
2,059 |
$7K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
95 |
79 |
$7K |
| J1815 |
Injection, insulin, per 5 units |
1,047 |
433 |
$7K |
| 80164 |
|
834 |
733 |
$6K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
154 |
144 |
$6K |
| J7050 |
Infusion, normal saline solution, 250 cc |
539 |
318 |
$6K |
| 82570 |
|
2,291 |
1,971 |
$6K |
| 88313 |
|
1,266 |
1,189 |
$6K |
| 88342 |
|
653 |
589 |
$6K |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
2,806 |
1,918 |
$6K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,344 |
1,156 |
$6K |
| 76825 |
|
13 |
13 |
$6K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
939 |
920 |
$6K |
| 70491 |
|
86 |
80 |
$6K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
660 |
647 |
$6K |
| 90651 |
|
98 |
92 |
$6K |
| 94770 |
|
38 |
38 |
$6K |
| 83615 |
|
3,360 |
2,068 |
$5K |
| 73080 |
|
474 |
446 |
$5K |
| 82784 |
|
650 |
450 |
$5K |
| 87581 |
|
910 |
899 |
$5K |
| 87486 |
|
910 |
899 |
$5K |
| 96523 |
|
44 |
37 |
$5K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
1,521 |
1,357 |
$5K |
| 73090 |
|
442 |
401 |
$5K |
| 96127 |
|
896 |
855 |
$5K |
| 82248 |
|
1,173 |
730 |
$5K |
| 76775 |
|
129 |
127 |
$5K |
| 95800 |
|
17 |
15 |
$5K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,677 |
1,294 |
$5K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
14 |
12 |
$4K |
| 72100 |
|
303 |
295 |
$4K |
| 97166 |
|
41 |
41 |
$4K |
| 74019 |
|
392 |
385 |
$4K |
| L8699 |
Prosthetic implant, not otherwise specified |
263 |
248 |
$4K |
| 72170 |
|
285 |
273 |
$4K |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
1,943 |
1,477 |
$4K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
4,243 |
2,965 |
$4K |
| 84550 |
|
2,892 |
1,728 |
$4K |
| 86480 |
|
95 |
89 |
$4K |
| 12001 |
|
124 |
118 |
$4K |
| 0064A |
|
121 |
118 |
$4K |
| 29580 |
|
34 |
13 |
$4K |
| 90734 |
|
74 |
64 |
$4K |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,773 |
1,079 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,310 |
1,259 |
$3K |
| 88312 |
|
1,083 |
1,038 |
$3K |
| 74022 |
|
294 |
287 |
$3K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
700 |
614 |
$3K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
707 |
412 |
$3K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
1,479 |
1,318 |
$3K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
3,027 |
1,887 |
$3K |
| 87999 |
|
1,254 |
1,229 |
$3K |
| 90688 |
|
221 |
219 |
$3K |
| 84156 |
|
1,616 |
1,324 |
$3K |
| 80320 |
|
451 |
398 |
$3K |
| 0071A |
|
73 |
73 |
$3K |
| 88300 |
|
1,354 |
1,327 |
$3K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
791 |
753 |
$3K |
| 0072A |
|
64 |
63 |
$3K |
| 84480 |
|
224 |
212 |
$3K |
| 73552 |
|
230 |
200 |
$3K |
| 93880 |
|
39 |
37 |
$3K |
| 76604 |
|
129 |
121 |
$3K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
47 |
36 |
$3K |
| 80047 |
|
2,003 |
1,817 |
$3K |
| 0012A |
|
94 |
94 |
$3K |
| 87205 |
|
696 |
630 |
$3K |
| 82010 |
|
1,010 |
882 |
$3K |
| 73140 |
|
289 |
277 |
$3K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
62 |
58 |
$2K |
| 97018 |
|
51 |
13 |
$2K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
481 |
287 |
$2K |
| 0011A |
|
86 |
84 |
$2K |
| 90723 |
|
645 |
601 |
$2K |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
19 |
19 |
$2K |
| 90681 |
|
801 |
709 |
$2K |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
2,037 |
1,475 |
$2K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,509 |
1,047 |
$2K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
30 |
12 |
$2K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
2,364 |
1,171 |
$2K |
| 74230 |
|
36 |
36 |
$2K |
| 97035 |
|
33 |
12 |
$2K |
| 99442 |
|
36 |
36 |
$2K |
| 90656 |
|
316 |
291 |
$2K |
| 82247 |
|
472 |
292 |
$2K |
| 82378 |
|
135 |
119 |
$2K |
| 86780 |
|
117 |
114 |
$2K |
| 29125 |
|
77 |
77 |
$2K |
| 85055 |
|
59 |
24 |
$1K |
| C9113 |
Injection, pantoprazole sodium, per vial |
2,104 |
1,445 |
$1K |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
1,131 |
457 |
$1K |
| 94760 |
|
35 |
32 |
$1K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
588 |
447 |
$1K |
| D1110 |
Prophylaxis - adult |
139 |
139 |
$1K |
| 73700 |
|
40 |
37 |
$1K |
| 86308 |
|
471 |
446 |
$1K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
45 |
45 |
$1K |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,162 |
842 |
$1K |
| 80074 |
|
85 |
84 |
$1K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
33 |
13 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,112 |
1,795 |
$1K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
16 |
16 |
$1K |
| 10060 |
|
46 |
42 |
$1K |
| 12002 |
|
41 |
39 |
$1K |
| 82043 |
|
429 |
393 |
$1K |
| 87641 |
|
253 |
220 |
$1K |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,367 |
885 |
$1K |
| J3360 |
Injection, diazepam, up to 5 mg |
331 |
226 |
$1K |
| 76998 |
|
18 |
12 |
$1K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
82 |
82 |
$1K |
| 87420 |
|
580 |
575 |
$1K |
| 86618 |
|
203 |
184 |
$985.70 |
| D0120 |
Periodic oral evaluation - established patient |
110 |
110 |
$983.50 |
| 86592 |
|
509 |
442 |
$973.70 |
| 88173 |
|
27 |
27 |
$930.26 |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
21 |
21 |
$927.72 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
602 |
406 |
$910.38 |
| 76857 |
|
12 |
12 |
$892.31 |
| 86803 |
|
135 |
112 |
$884.07 |
| 88341 |
|
27 |
25 |
$882.93 |
| 86850 |
|
177 |
166 |
$873.24 |
| 76001 |
|
42 |
41 |
$871.16 |
| 85014 |
|
2,094 |
1,862 |
$855.15 |
| 87640 |
|
259 |
228 |
$840.30 |
| 73560 |
|
87 |
81 |
$830.74 |
| 85378 |
|
191 |
186 |
$818.18 |
| 87147 |
|
631 |
605 |
$798.15 |
| 97164 |
|
12 |
12 |
$789.02 |
| J3411 |
Injection, thiamine hcl, 100 mg |
165 |
98 |
$777.92 |
| 80076 |
|
216 |
201 |
$747.52 |
| 0124A |
|
28 |
27 |
$741.86 |
| 83520 |
|
48 |
39 |
$725.60 |
| 84132 |
|
272 |
229 |
$690.04 |
| 82977 |
|
904 |
366 |
$685.47 |
| 87340 |
|
197 |
172 |
$683.86 |
| 82150 |
|
333 |
314 |
$678.85 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
40 |
37 |
$671.18 |
| Q3014 |
Telehealth originating site facility fee |
55 |
49 |
$627.36 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
605 |
410 |
$602.91 |
| J1940 |
Injection, furosemide, up to 20 mg |
149 |
87 |
$597.31 |
| Q9953 |
Injection, iron-based magnetic resonance contrast agent, per ml |
25 |
25 |
$596.07 |
| 86617 |
|
71 |
71 |
$585.94 |
| 84560 |
|
268 |
247 |
$577.98 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
299 |
239 |
$566.88 |
| 86141 |
|
398 |
356 |
$542.52 |
| 82140 |
|
179 |
122 |
$541.53 |
| 96040 |
|
13 |
13 |
$539.82 |
| J3371 |
Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg |
72 |
52 |
$513.83 |
| 0031A |
|
16 |
16 |
$510.64 |
| 86038 |
|
82 |
62 |
$507.72 |
| 84481 |
|
44 |
42 |
$507.59 |
| 86870 |
|
17 |
12 |
$496.41 |
| 80177 |
|
69 |
63 |
$492.62 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
762 |
684 |
$488.27 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
46 |
25 |
$478.09 |
| 97799 |
|
58 |
40 |
$454.74 |
| 90716 |
|
76 |
61 |
$453.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
57 |
38 |
$437.66 |
| 90697 |
|
569 |
543 |
$430.81 |
| 12011 |
|
24 |
24 |
$428.68 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
178 |
154 |
$418.31 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
458 |
343 |
$416.77 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
397 |
314 |
$413.63 |
| 84153 |
|
62 |
52 |
$406.37 |
| J2790 |
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
14 |
13 |
$398.27 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
616 |
436 |
$383.71 |
| 84146 |
|
14 |
12 |
$365.89 |
| 90647 |
|
331 |
271 |
$354.59 |
| 72040 |
|
27 |
24 |
$330.49 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
349 |
186 |
$294.67 |
| 90707 |
|
115 |
92 |
$292.69 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
446 |
355 |
$272.12 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
534 |
462 |
$261.01 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
44 |
42 |
$254.60 |
| 87899 |
|
101 |
94 |
$249.81 |
| 86706 |
|
69 |
55 |
$241.99 |
| 82565 |
|
678 |
627 |
$237.23 |
| 73060 |
|
28 |
26 |
$234.89 |
| 88112 |
|
21 |
14 |
$230.14 |
| 83970 |
|
25 |
19 |
$217.66 |
| 88172 |
|
12 |
12 |
$209.64 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
114 |
92 |
$207.92 |
| 86704 |
|
54 |
42 |
$181.14 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
144 |
90 |
$177.40 |
| 85384 |
|
118 |
50 |
$177.23 |
| OP637 |
|
19,885 |
2,730 |
$176.19 |
| 87076 |
|
28 |
28 |
$160.60 |
| 82533 |
|
16 |
13 |
$160.16 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
14 |
13 |
$156.98 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
66 |
39 |
$151.42 |
| 87390 |
|
12 |
12 |
$148.14 |
| J1953 |
Injection, levetiracetam, 10 mg |
64 |
46 |
$141.52 |
| 86665 |
|
33 |
27 |
$139.77 |
| 84436 |
|
27 |
27 |
$137.82 |
| 86769 |
|
16 |
12 |
$131.05 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
403 |
304 |
$122.49 |
| 80069 |
|
18 |
14 |
$119.82 |
| 90633 |
|
479 |
402 |
$118.59 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
78 |
40 |
$111.38 |
| C1770 |
Imaging coil, magnetic resonance (insertable) |
14 |
12 |
$107.91 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
28 |
16 |
$97.82 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
69 |
57 |
$96.89 |
| 90671 |
|
115 |
104 |
$96.00 |
| 87015 |
|
97 |
89 |
$90.48 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
158 |
92 |
$76.86 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
226 |
147 |
$75.16 |
| 86431 |
|
15 |
12 |
$64.81 |
| 86364 |
|
15 |
12 |
$64.23 |
| 84165 |
|
13 |
12 |
$52.06 |
| 86664 |
|
15 |
12 |
$50.10 |
| 82270 |
|
13 |
13 |
$49.32 |
| 99151 |
|
12 |
12 |
$48.98 |
| J0290 |
Injection, ampicillin sodium, 500 mg |
39 |
14 |
$48.71 |
| 73070 |
|
23 |
12 |
$43.91 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
27 |
14 |
$38.54 |
| 87045 |
|
40 |
38 |
$36.00 |
| 87536 |
|
14 |
14 |
$35.60 |
| J0737 |
Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg |
16 |
12 |
$34.91 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
36 |
26 |
$34.27 |
| D1206 |
Topical application of fluoride varnish |
26 |
24 |
$33.00 |
| J3590 |
Unclassified biologics |
203 |
197 |
$31.50 |
| J7510 |
Prednisolone oral, per 5 mg |
169 |
153 |
$29.32 |
| 84300 |
|
13 |
12 |
$28.80 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
118 |
114 |
$26.58 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
85 |
81 |
$23.86 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
56 |
46 |
$15.98 |
| 90380 |
|
32 |
32 |
$15.57 |
| Q0239 |
Injection, bamlanivimab-xxxx, 700 mg |
17 |
17 |
$14.00 |
| 90381 |
|
28 |
27 |
$12.47 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
160 |
114 |
$10.63 |
| 84155 |
|
15 |
13 |
$9.04 |
| 91300 |
|
2,484 |
2,204 |
$9.01 |
| 90700 |
|
36 |
30 |
$3.00 |
| J3372 |
Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg |
22 |
16 |
$1.31 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
109 |
105 |
$1.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
99 |
96 |
$1.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
47 |
44 |
$0.00 |
| Q0245 |
Injection, bamlanivimab and etesevimab, 2100 mg |
23 |
19 |
$0.00 |
| 91312 |
|
28 |
27 |
$0.00 |
| 91301 |
|
192 |
190 |
$0.00 |
| 91306 |
|
110 |
106 |
$0.00 |
| 87507 |
|
12 |
12 |
$0.00 |
| 86361 |
|
16 |
12 |
$0.00 |
| 91307 |
|
119 |
104 |
$0.00 |
| Q0222 |
Injection, bebtelovimab, 175 mg |
18 |
18 |
$0.00 |
| J0687 |
Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg |
69 |
44 |
$0.00 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
12 |
12 |
$0.00 |